Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunotherapy. 2013 Feb;5(2):155-67. doi: 10.2217/imt.12.155.

Vaccine strategies for glioblastoma: progress and future directions.

Author information

1
The Johns Hopkins Hospital, Department of Neurosurgery, Baltimore, MD 21287, USA.

Abstract

Recent advances in glioblastoma therapy have led to optimism that more effective therapies will improve outcomes. Immunotherapy is a promising approach that has demonstrated the potential to eradicate cancer cells with cellular-level accuracy while minimizing damage to surrounding healthy tissue. Several vaccination strategies have been evaluated for activity against glioblastoma in clinical trials. These include peptide vaccines, polyvalent dendritic cell vaccines, heat shock protein vaccines and adoptive immunotherapy. In this review, we highlight clinical trials representative of each of these approaches and discuss strategies for integrating these therapies into routine patient care.

PMID:
23413907
PMCID:
PMC4086484
DOI:
10.2217/imt.12.155
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Support Center